| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |